Cycurion is trading at $0.65, +5.78%, with no verified company-specific reason identified for the intraday rise.
- Shares remain listed while the August 20, 2026 Nasdaq hearing is pending; available reporting does not identify a new August 10 catalyst.
- Recent warrant financing involves approximately $4.5 million in proceeds and potentially substantial future dilution, continuing to weigh on sentiment.
- The Nasdaq is down 0.33% amid mixed markets, so macro conditions do not clearly explain the gain; the move appears speculative or technical.